Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

Por Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M Zetola, Drew Weissman, Tawanda Gumbo, Gregory P Bisson
Publicado em 2017-01-01

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis

Por Justin Shenje, F. Ifeoma Adimora-Nweke, Ian L. Ross, Mpiko Ntsekhe, Lubbe Wiesner, Armin Deffur, Helen M. McIlleron, Jotam Pasipanodya, Tawanda Gumbo, Bongani M. Mayosi
Publicado em 2015-11-01